LGALS3 and hydrops fetalis: In 16 of the 18 studies, elevated galectin-3 levels were found to be significantly associated with HFpEF patients vs. controls, distinguished between HFpEF and other HF subtypes, or correlated positively with other well-established markers of cardiac dysfunction.